InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Olson Kenneth Fletcher, Chief Operating Officer. Insider active across 2 companies, notably HARVARD BIOSCIENCE INC. In total, 6 reports have been recorded. The latest transaction was disclosed on 29 December 2021 — Retenue fiscale. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
€18,0682,812 shares@ €6.425264.8% of flow
Common Stock
SEC:0000921895-21-002906·
€18,0682,812 shares@ €6.42520.060% mcap32.4% of flow
Common Stock
SEC:0000921895-21-002906:0·
€9,8151,539 shares@ €6.377335.2% of flow
Common Stock
SEC:0000921895-21-002516·
€9,8151,539 shares@ €6.37730.033% mcap17.6% of flow
Common Stock
SEC:0000921895-21-002516:0·
018,378 shares0
Common Stock
SEC:0000921895-21-001648·
018,378 shares0
Common Stock
SEC:0000921895-21-001648:0·
6 of 6 declarations
About Olson Kenneth Fletcher
Kenneth Fletcher Olson is the Chief Operating Officer at Harvard Bioscience Inc. He oversees the company's operations, playing a key role in operational efficiency and strategy implementation.
